BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31829777)

  • 1. Evaluation of
    Shahsavari S; Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Int J Radiat Biol; 2020 Apr; 96(4):502-509. PubMed ID: 31829777
    [No Abstract]   [Full Text] [Related]  

  • 2. An improved
    Khodadust F; Ahmadpour S; Aligholikhamseh N; Abedi SM; Hosseinimehr SJ
    Eur J Med Chem; 2018 Jan; 144():767-773. PubMed ID: 29291444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
    Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
    Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
    J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricine co-ligand improved the efficacy of
    Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetic, biodistribution, radiation dosimetry, and toxicity studies of
    Biabani Ardakani J; Talebpour Amiri F; Khorramimoghaddam A; Abbasi A; Molavipordanjani S; Hosseinimehr SJ
    Regul Toxicol Pharmacol; 2020 Apr; 112():104591. PubMed ID: 32006673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Usefulness of
    Avan Z; Biabani Ardakani J; Talebpour Amiri F; Abedi SM; Hosseinimehr SJ
    Cancer Biother Radiopharm; 2022 Nov; 37(9):862-869. PubMed ID: 32898439
    [No Abstract]   [Full Text] [Related]  

  • 9. Technetium-99m- Arg-Arg-Leu(g2), a modified peptide probe targeted to neovascularization in molecular tumor imaging.
    Lu X; Zhao L; Xue T; Zhang H
    J BUON; 2013; 18(4):1074-81. PubMed ID: 24344042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
    Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
    J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, radiolabeling and evaluation of [
    Dinmohammadi F; Erfani M; Shamsaei M; Shirmardi SP; Goudarzi M
    Bioorg Chem; 2023 Jan; 130():106237. PubMed ID: 36402025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of
    Maleki F; Masteri Farahani A; Sadeghzadeh N; Mardanshahi A; Abediankenari S
    Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H; Miao Y
    J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
    Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Chem Biol Drug Des; 2018 Jul; 92(1):1214-1220. PubMed ID: 29441688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of a
    Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
    Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.